Assenagon Asset Management S.A. Neurocrine Biosciences Inc Transaction History
Assenagon Asset Management S.A.
- $47.8 Billion
- Q3 2024
A detailed history of Assenagon Asset Management S.A. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 29,803 shares of NBIX stock, worth $3.71 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
29,803
Previous 249,424
88.05%
Holding current value
$3.71 Million
Previous $34.3 Million
90.01%
% of portfolio
0.01%
Previous 0.09%
Shares
19 transactions
Others Institutions Holding NBIX
# of Institutions
621Shares Held
95.2MCall Options Held
661KPut Options Held
221K-
Black Rock Inc. New York, NY14.2MShares$1.76 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.25 Billion0.03% of portfolio
-
State Street Corp Boston, MA4.61MShares$573 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.47MShares$307 Million0.6% of portfolio
-
Jpmorgan Chase & CO New York, NY2.36MShares$294 Million0.03% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.9B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...